Wells' syndrome (eosinophilic cellulitis): Correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 127-130

  Espana A ^a   Sanz, M L ^a   Sola, J ^a   Gil, P ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Eosinophil cation protein; Eosinophilic cellulitis; Interleukin 5; Well's syndrome

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 5; LYMPHOKINE; MESSENGER RNA;

ADULT; ARTICLE; BONE MARROW; CASE REPORT; DISEASE ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE; WELLS SYNDROME;

ADULT; BLOOD PROTEINS; CELLULITIS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; LEUKOCYTE COUNT; RIBONUCLEASES; SYNDROME;

EID: 0032973011     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02621.x     Document Type: Article

References (20)

1. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med 1968; 68: 1220-9.
2. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc 1971; 57: 46-56.
3. Bogenrieder T, Griese DP, Schiffner R et al. Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol 1997; 137: 978-82.
4. Kaufman LD. The expanding clinical spectrum of multisystem disease associated with eosinophilia. Arch Intern Med 1997; 133: 225-7.
5. Leiferman Gleich GJ. Cutaneous eosinophilic diseases. In: Dermatology in General Medicine (Fitzpatrick TB, Eisen AZ, Wolff K et al., eds), 4th edn. New York: McGraw-Hill, Inc., 1993: 1156-64.
6. Yagui H, Matsushita K, Hanaoka K et al. Wells' syndrome: A pathogenic role for circulating CD4+ CD7- T cells expressing interleukin-5 MRNA. Br J Dermatol 1997; 136: 918-23.
7. Peters MS, Schroeter AL, Gleich GJ. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 1983; 109: 141-8.
8. Trüeb RM, Lübbe J, Torricelli R et al. Eosinophilic myositis with eosinophilic celulitis-like skin lesions. Association with increased serum levels of eosinophil cation protein and interleukin-5. Arch Dermatol 1997; 133: 203-6.
9. Silberstein DS, Austen KF, Owen WF Jr. Hemopoietins for eosinophils: Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated diseases. Hematol Oncol Clin North Am 1989; 3: 511-33.
10. Rothenberg ME, Petersen J, Stevens RL et al. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143: 2311-16.
11. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79: 3101-9.
12. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 1990; 172: 1425-31.
13. Coffman RL, Seymour BWP, Hudak S et al. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245: 308-10.
14. Das AM, Williams TJ, Lobb R, Nourshargh S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology 1995; 84: 41-6.
15. Tomassini M, Tsicopoulos A, Tai PC et al. Release of granule proteins by eosinophils from allergic and non allergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol 1991; 88: 365-75.
16. Abu-Ghazaleh RI, Fujisawa T, Mestecky J et al. IgA-induced eosinophil degranulation. J Immunol 1989; 142: 2393-400.
17. Sauder DN, Dytoc MT. Cytokines. Curr Probl Dermatol 1997; 9: 5-30.
18. Hatake K, Arai K, Yokota T. Interleukin-5. In: Human Cytokines: Handbook for Basic and Clinical Research (Aggarwal BB, Gutterman JU, eds). Cambridge. MA: Blackwell Scientific Publications, 1992: 130-42.
19. Cox NH, Venge P, Friedmann PS. Eosinophilic cationic protein in dermatitis herpetiformis, bullous pemphigoid, and other blistering disorders. Eur J Dermatol 1993; 3: 294-7.
20. Czech W, Schaller J, Schopf E, Kapp A. Granulocyte activation in bullous diseases: Release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 1993; 29: 210-15.